Status:
ACTIVE_NOT_RECRUITING
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Postural Tachycardia Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The investigators will test whether an intravenous infusion of saline (salt water) will improve the exercise capacity in patients with postural tachycardia syndrome (POTS).
Eligibility Criteria
Inclusion
- Meet diagnostic criteria of Postural Tachycardia Syndrome (POTS) 28
- Age between 18-65 years
- Male and female are eligible (although the majority of POTS patients are female).
- Able and willing to provide informed consent
Exclusion
- Presence of medical conditions that can explain postural tachycardia (e.g., acute dehydration, medications)
- Pregnancy
- Other factors which in the investigator's opinion would prevent the subject from completing the protocol.
- Patients who are bedridden or chair-ridden
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01000350
Start Date
October 1 2009
End Date
June 1 2028
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University
Nashville, Tennessee, United States, 37232-2195